University of Patras
Συσχέτιση των νευροϊνιδίων χαμηλού μοριακού βάρους (NfL) και άλλων γενετικών βιοδεικτών με τη νευροτοξικότητα που προκαλείται από τη χορήγηση χημειοθεραπείας
Abstract
dc:descriptionBackground and Objective: There is compelling experimental evidence that neurofilament light chain (NfL) could sensitively be detected in serum as a biomarker of neuro-axonal damage induced by chemotherapy. We sought to assess the significance of measuring serum NfL (sNfL) in the clinical setting of paclitaxel-induced peripheral neurotoxicity (PIPN). Materials and methods: We longitudinally measured sNfL in breast cancer patients, scheduled to receive the 12-weekly paclitaxel-based regimen. Patients were clinically examined by means of the Total Neuropathy Score–clinical version (TNSc), while sNfL levels were quantified, using the highly-sensitive Simoa technique, before the onset of chemotherapy (baseline), after 2 (week 2) and 3 (week 3) weekly courses, and at the end of chemotherapy (week 12). Results: Among 59 included patients (mean age: 53.1 ± 11.5 years), 33 (56%) developed grade 0-1 and 26 (44%) grade 2-3 PIPN at week 12. A significant longitudinal increase of sNfL levels from baseline to week 12 was determined, whereas patients with TNSc grade 2-3 PIPN had significantly increased sNfL levels at week 12, compared to those with grade 0-1 PIPN. Receiver-operated characteristics (ROC) analysis defined a value of NfL of > 85 pg/mL at week 3 as the best discriminative determination to predict the development of grade 2-3 PIPN at week 12 (sensitivity 46.2%, specificity 84.8%). The logistic binary regression analysis revealed that age > 50 years and the cutoff of >85 pg/mL of sNfL levels at week 3 independently predicted the development of grade 2-3 PIPN at week 12 with a sensitivity of 46%, a specificity of 91%, and positive and negative predictive values of 75% and 67%, respectively. Conclusions: NfL levels seem to be a valuable biomarker of neuro-axonal injury in PIPN. An early increase of this biomarker after a 3-weekly chemotherapy course can be a predictive marker of final PIPN severity.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karteri, Sofia
- Καρτέρη, Σοφία
Subjects
dc:subject × 15- Βιοδείκτες
- Περιφερική νευροτοξικότητα
- Χημειοθεραπεία
- Πακλιταξέλη
- Νευροϊνίδια χαμηλού μοριακού βάρους
- Biomarkers
- Chemotherapy-induced peripheral neurotoxicity
- Paclitaxel
- Serum neurofilament light chain
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ογκολογία
- Clinical Medicine
- Medical and Health Sciences
- Oncology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55060